Biocept Stock Market Value

BIOCQ Stock   0.0001  0.0001  50.00%   
Biocept's market value is the price at which a share of Biocept trades on a public exchange. It measures the collective expectations of Biocept investors about its performance. Biocept is selling at 1.0E-4 as of the 28th of December 2025; that is 50% down since the beginning of the trading day. The stock's last reported lowest price was 1.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Biocept and determine expected loss or profit from investing in Biocept over a given investment horizon. Check out Biocept Correlation, Biocept Volatility and Biocept Alpha and Beta module to complement your research on Biocept.
To learn how to invest in Biocept Stock, please use our How to Invest in Biocept guide.
Symbol

Biocept Price To Book Ratio

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocept. If investors know Biocept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocept listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(48.17)
Revenue Per Share
1.965
Quarterly Revenue Growth
(0.90)
Return On Assets
(0.52)
Return On Equity
(1.87)
The market value of Biocept is measured differently than its book value, which is the value of Biocept that is recorded on the company's balance sheet. Investors also form their own opinion of Biocept's value that differs from its market value or its book value, called intrinsic value, which is Biocept's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocept's market value can be influenced by many factors that don't directly affect Biocept's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocept's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biocept is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocept's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biocept 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biocept's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biocept.
0.00
11/28/2025
No Change 0.00  0.0 
In 30 days
12/28/2025
0.00
If you would invest  0.00  in Biocept on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding Biocept or generate 0.0% return on investment in Biocept over 30 days. Biocept is entity of United States. It is traded as Stock on NASDAQ exchange. More

Biocept Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biocept's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biocept upside and downside potential and time the market with a certain degree of confidence.

Biocept Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biocept's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biocept's standard deviation. In reality, there are many statistical measures that can use Biocept historical prices to predict the future Biocept's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocept's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00009450.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.000350.01
Details
Naive
Forecast
LowNextHigh
0.0000090.0004125.47
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.00070.00020
Details

Biocept Backtested Returns

Biocept is out of control given 3 months investment horizon. Biocept secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of risk over the last 3 months. We were able to break down nineteen different technical indicators, which can help you to evaluate if expected returns of 14.69% are justified by taking the suggested risk. Use Biocept Mean Deviation of 58.9, risk adjusted performance of 0.094, and Standard Deviation of 234.66 to evaluate company specific risk that cannot be diversified away. Biocept holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 34.82, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biocept will likely underperform. Use Biocept variance, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to analyze future returns on Biocept.

Auto-correlation

    
  0.37  

Below average predictability

Biocept has below average predictability. Overlapping area represents the amount of predictability between Biocept time series from 28th of November 2025 to 13th of December 2025 and 13th of December 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biocept price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Biocept price fluctuation can be explain by its past prices.
Correlation Coefficient0.37
Spearman Rank Test-0.45
Residual Average0.0
Price Variance0.0

Biocept lagged returns against current returns

Autocorrelation, which is Biocept stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biocept's stock expected returns. We can calculate the autocorrelation of Biocept returns to help us make a trade decision. For example, suppose you find that Biocept has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Biocept regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biocept stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biocept stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biocept stock over time.
   Current vs Lagged Prices   
       Timeline  

Biocept Lagged Returns

When evaluating Biocept's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biocept stock have on its future price. Biocept autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biocept autocorrelation shows the relationship between Biocept stock current value and its past values and can show if there is a momentum factor associated with investing in Biocept.
   Regressed Prices   
       Timeline  

Pair Trading with Biocept

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocept position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocept will appreciate offsetting losses from the drop in the long position's value.

Moving against Biocept Stock

  0.39EQ EquilliumPairCorr
  0.36688578 Shanghai Allist PharPairCorr
The ability to find closely correlated positions to Biocept could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocept when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocept - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocept to buy it.
The correlation of Biocept is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocept moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocept moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocept can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Biocept Stock Analysis

When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.